Evidence map›Paper›PMID 33664273›Full record

ArticleNPJ genomic medicine2021

A cryptic splice-altering KCNQ1 variant in trans with R259L leading to Jervell and Lange-Nielsen syndrome.

Mario Torrado, Germán Fernández, Christian A Ganoza, Emilia Maneiro, Diego García, Natalia Sonicheva-Paterson, Isaac Rosa, Juan Pablo Ochoa, Luis Santomé, Elena Vasichkina and 1 more

Open access · goldAbstract read
In one paragraph

Article in NPJ genomic medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Advances in gene therapy hold promise for treating hereditary hearing loss.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Mario TorradoInstitute of Health Sciences, University of A Coruña, A Coruña, Spain. mario.torrado@udc.es.ORCID http://orcid.org/0000-0001-9762-7018
Germán FernándezCardiovascular Genetics, Health in Code, A Coruña, Spain.
Christian A GanozaCardiovascular Genetics, Health in Code, A Coruña, Spain.ORCID http://orcid.org/0000-0002-5891-5372
Emilia ManeiroCardiovascular Genetics, Health in Code, A Coruña, Spain.ORCID http://orcid.org/0000-0002-7671-2405
Diego GarcíaCardiovascular Genetics, Health in Code, A Coruña, Spain.
Natalia Sonicheva-PatersonCardiovascular Genetics, Health in Code, A Coruña, Spain.ORCID http://orcid.org/0000-0001-7766-1251
Isaac RosaCardiovascular Genetics, Health in Code, A Coruña, Spain.
Juan Pablo OchoaCardiovascular Genetics, Health in Code, A Coruña, Spain.
Luis SantoméCardiovascular Genetics, Health in Code, A Coruña, Spain.
Elena VasichkinaAlmazov National Medical Research Centre, Saint Petersburg, Russia.
Lorenzo MonserratCardiovascular Genetics, Health in Code, A Coruña, Spain.
Universidade da Coruña · ESFederal Almazov North-West Medical Research Centre · RU

Funding

Consellería de Economía, Emprego e Industria, Xunta de Galicia (Consellería de Economía e Industria, Xunta de Galicia) GRC ED431C 2018/38
6 · The paper itself

Abstract

Here we report an infant with clinical findings suggestive of Jervell and Lange-Nielsen syndrome (JLNS), including a prolonged QT interval (LQTS) and chronic bilateral sensorineural deafness. NGS analysis revealed one known heterozygous pathogenic missense variant, KCNQ1 p.R259L, previously associated with LQTS but insufficient to explain the cardioauditory disorder. In a screening of proximal intronic regions, we found a heterozygous variant, KCNQ1 c.1686-9 T > C, absent from controls and previously undescribed. Several splicing prediction tools returned low scores for this intronic variant. Driven by the proband's phenotype rather than the neutral predictions, we have characterized this rare intronic variant. Family analysis has shown that the proband inherited the missense and the intronic variants from his mother and father, respectively. A minigene splicing assay revealed that the intronic variant induced an additional transcript, arising from skipping of exon 14, which was translated into a truncated protein in transfected cells. The splice-out of exon 14 creates a frameshift in exon 15 and a stop codon in exon 16, which is the last exon of KCNQ1. This mis-spliced transcript is expected to escape nonsense-mediated decay and predicted to encode a truncated loss-of-function protein, KCNQ1 p.L563Kfs*73. The analysis of endogenous KCNQ1 expression in the blood of the proband's parents detected the aberrant transcript only in the patient's father. Taken together, these analyses confirmed the proband's diagnosis of JLNS1 and indicated that c.1686-9 T > C is a cryptic splice-altering variant, expanding the known genetic spectrum of biallelic KCNQ1 variant combinations leading to JLNS1.

Identifiers

PMID33664273
PMCPMC7933243
OpenAlexW3135674611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.